Bioquest Corp
Datakwaliteit: 83%
BQST
OTC
Manufacturing
Chemicals
€ 0,51
▲
€ 0,04
(8,45%)
Marktkapitalisatie: 15,28 M
Prijs
€ 0,51
Marktkapitalisatie
15,28 M
Dagbereik
€ 0,51 — € 0,51
52-Weeksbereik
€ 0,47 — € 1,05
Volume
12
Openen € 0,51
50D / 200D Gem.
€ 0,50
2,88% above
50D / 200D Gem.
€ 0,71
27,57% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -72.781,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,03
Interest Coverage-47,43
Waardering
PE (TTM)
-30,11
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -30,1 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -507.406,0 |
| ROE | N/A | ROA | -6733,54% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -72.781,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,03 |
| Interest Coverage | -47,43 | Asset Turnover | N/A |
| Working Capital | -536.419 | Tangible Book Value | -536.419 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -30,11 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0,48% | ||
| Market Cap | 15,28 M | Enterprise Value | 15,26 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 14,34% |
| SBC-Adj. FCF | -222.781 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2022 | FY2021 | FY2014 |
|---|---|---|---|
| Revenue | — | — | 0,0 |
| Net Income | -821.022,0 | -2,32 M | -616.186,0 |
| EPS (Diluted) | — | — | — |
| Gross Profit | — | — | — |
| Operating Income | -817.920,0 | -2,20 M | -251.903,0 |
| EBITDA | — | — | — |
| R&D Expenses | — | — | — |
| SG&A Expenses | — | — | — |
| D&A | — | — | — |
| Interest Expense | 30.000,0 | 37.638,0 | — |
| Income Tax | — | — | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2022 | FY2021 | FY2014 |
|---|---|---|---|
| Total Assets | 33.540,0 | 17.097,0 | 889.903,0 |
| Total Liabilities | 466.530,0 | 1,79 M | 14.700,0 |
| Shareholders' Equity | -432.990,0 | -1,77 M | 875.203,0 |
| Total Debt | — | — | — |
| Cash & Equivalents | 33.540,0 | 260,0 | 543.853,0 |
| Current Assets | 33.540,0 | 17.097,0 | 889.903,0 |
| Current Liabilities | 466.530,0 | 1,79 M | 14.700,0 |
{"event":"ticker_viewed","properties":{"ticker":"BQST","listing_kind":"stock","pathname":"/stocks/bqst","exchange":"OTC","country":"US"}}